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Unique  antigenic  determinants  found on antibodies of a  particular specificity are 
called idiotypes (Id); inbred mouse strains have been shown to inherit  the ability to 
express a particular Id during responses to the same antigen in a reproducible manner. 
In general, these studies have shown that the genes controlling the expression of an Id 
are linked to the immunoglobulin heavy-chain gene complex (Ig-H). 1 Where crossing 
over between  the  genes coding for constant  portion  of the  Ig-H complex  (CH)  and 
variable  portion  of the  Ig-H  complex  (VH)  have  occurred,  the  Id  is  inherited  in 
linkage with VH (i). More recently, light-chain polymorphisms have been described, 
and these genes have also been demonstrated to affect the expression of the Id (2, 3). 
One of these polymorphisms is located in the genes of variable region of immunogo- 
bulin ~¢-light chains (VJ¢) (2, 4). This was first detected by tryptic peptide mapping of 
cysteine-containing  peptides  from  VK  by  Edelman  and  Gottlieb  (4),  and  it  was 
subsequently  demonstrated  to  be  linked  to  a  genetic  locus on  chromosome 6  that 
controls the T  cell differentiation antigen Lyt-3.1 (5).  Studies by Claflin et al.  (6) and 
by Gibson  (7)  have defined similar K-chain polymorphisms. Mice of strains that bear 
the Lyt-3.1 allele  (AKR, C58, PL, and RF) express one pattern of Vtc-gene products, 
whereas  all  Lyt-3.2  strains  express  a  different  pattern.  More  recently,  Gibson  and 
MacLean  (8)  have  detected  an  electrophoretic  difference  bewteen  certain  K-light 
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chains from strain C58 and the other Lyt-3.1 strains of mice, which they have termed 
Ef-2 (8). They propose that this difference involves a  single VK group. 
Previous  work  in  our  laboratories  has  enabled  us  to  define  a  set  of  reagents 
detecting  an  idiotype on  the  BALB/e  2,4-dinitrophenyl  (DNP)-binding  myeloma 
protein MOPC  460  (Id-460)  (9,  10)  that is inherited by strains of mice that carry the 
Ig-H complex derived from  BALB/c mice  (11).  Id-460  is expressed during conven- 
tional  anti-DNP  antibody responses  in  vivo. In  these experiments, a  different  set  of 
reagents  has  been  prepared  that  define  a  related  Id-460  determinant.  We  have 
determined the time-course of expression of Id-460 during primary and secondary in 
vivo anti-DNP antibody responses. In this paper, we demonstrate that the expression 
of Id-460 during in vivo anti-DNP antibody responses is controlled by genes mapping 
in VH. We further demonstrate that VK genes present in strains BALB/c and AKR, 
but  missing or unexpressed in strain C58,  are required for the expression of Id-460. 
This is the first Id to clearly differentiate the VK repertoire of strains C58 and AKR. 
Materials  and  Methods 
Mice.  Mice of strains  BALB/eByJ  and  B10.D2/oSn  were  purchased  from  The Jackson 
Laboratory,  Bar  Harbor,  Maine.  The  major  histocompatibility complex  (MHC)-congenic 
strains  BALB.B  (H-2  b)  and  BALB.K  (H-2  k)  were  provided  by  Donal  Murphy  from  the 
Comprehensive Cancer Center, Yale University, New Haven, Conn. Strain C.B20 was obtained 
from  Litton  Bionetics under  contract  to  Michael  Potter  (National Cancer  Institute  [NCI] 
contract  NO I-CB-92142)  and  strains BAB-14 and  B.C9  were  gifts of Roy Riblet and  Mel 
Bosma at the Institue for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pa.; these 
Ig-congenic strains were maintained at Yale from stock provided. Strains BALB/C58-Lyt-2a,3  a 
(C.C58)  and  BALB/AKR-Lyt-2a,3  a  (C.AKR)  were  bred  at  the  Massachusetts  Institute of 
Technology,  Cambridge,  Mass.  by  introgressively  backcrossing  the  Lyt-3.1  marker  onto 
BALB/cAnN mice  (12).  The  generations of backcrossing and  inbreeding of .these  mice was 
N19F3 for C.C58 and N18F3 for C.AKR. Mice of both strains bear the Lyt-3  a allele and the 
V~  IB  peptide marker  associated with  this  allele in  the  parental  strains.  The  (CBA/N  × 
BALB/c)F1 male mice bred from CBA/N maintained at Yale and BALB/cByJ express the X- 
linked immune  deficiency (Xid)  found in CBA/N  mice whereas the reciprocal (BALB/c × 
CBA/N)F1 male mice are phenotypically normal. 
Myleoma Proteins.  MOPC 460, MOPC 31C, FLOPC 21, and MOPC  104E plasmacytomas 
along  with  proteins XRPC-25  and  TEPC-15  were  obtained  from  Michael  Potter  (Litton 
Bionetics under NCI contract NO1-CB-92142).  The plasmacytomas were carried in  BALB/ 
cByJ mice as ascites tumors. Ascites fluid was precipitated in 45% saturated ammonium sulfate 
at 4°C.  MOPC 460 and MOPC 315 proteins were purified by affinity chromatography using 
DNP-lysyl-glycine-Sepharose  (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, 
N. J.). MOPC 31C and FLOPC 21  were further purified by DEAE-ion-exchange chromatog- 
raphy.  MOPC  104E  was  purified on  Sephacryl S-300  (Pharmacia  Fine Chemicals, Div.  of 
Pharmacia, Inc.). MOPC 511  protein was a gift from Rose Liebermann, National Institutes of 
Health (NIH) and affinity-purified HOPC-8 was a gift from Stuart Rudikoff (NIH). G-1 is a 
monoclonal  antibody  from  BALB/c  mice;  it  binds  both  DNP  and  phosphorylcholine  (P. 
Gearhart. Unpublished observations.). 
Anti-ld  Antisera.  Anti-Id-460 antiserum was produced by immunization of New  Zealand 
White rabbits with 500/~g MOPC 460  (M460) emulsified in complete Freund's adjuvant and 
given  intraperitoneally. Rabbits were blocked for production of antibody to  the  315  Id by 
intravenous injection of 20 mg MOPC 315  (M315) protein immediately before immunization. 
3 wk after primary immunization, the rabbits were boosted with 500 pg of M460 protein in 
incomplete Freund's adjuvant intraperitoneally. Again, rabbits received 20 mg of M315 protein 
intravenously. A further boost of 2 mg of an alum precipitate of M460 protein was given 16 d 
later as three successive intravenous injections. After immunization, rabbits were bled at 2-wk 
intervals by cardiac puncture.  Antibodies specific for Id-460 were detected by Ouchterlony 722  C-ENET1C  CONTROIJ OF  EXPRESSION  OF  IDIOTYPE  ld-460 
double-diffusion analysis using M315,  HOPC-8, and  MOPC  511  proteins and  normal  mouse 
serum  for comparison.  Purification  of rabbit  antibodies  directed  against  the  hapten-binding 
site of the Id-460 was by a  modification of the procedure of Claflin and Davie (13).  To remove 
shared  public specificities, 6  ml of antiserum  was  passed  through  a  10-ml  column of M315- 
Sepharose. The excluded volume of this column was then absorbed to a  10-ml column of M460- 
Sepharose  equilibrated  in  phosphate-buffered  saline  (PBS).  After  a  wash  of five times  the 
column volume with PBS, elution of antibody directed to the hapten-binding site of M460 was 
performed  with 6  ml of 0.05  M  DNP-L-glycine in  PBS.  The  DNP  eluate  was collected and 
dialyzed exhaustively against  PBS. Antibody yields averaged ~300 p,g/ml serum. The purified 
anti-Id-460 Id antibody was stored in PBS at -20°C. 
Antigens and Immunization of Mice.  Ovalbumin  (OVA),  bovine serum  albumin  (BSA)  and 
their  DNP-conjugates,  DNPs-OVA  and  DNP2s-BSA,  were  prepared  as  previously described 
(14). 
Mice were  immunized  by  injecting 2  ×  109 Bordetella pertussis organisms  intraperitoneally 
followed by  100/tg of an alum precipitate of DNPs-OVA (14).  A boosting immunization of 10 
p,g DNPs-OVA  (in  PBS-D or as  an  alum  precipitate)  was  given intraperitoneally  21  d  later. 
These mice were bled from the orbital plexus at the time of immunization and at various days 
after both the primary injection and the boost. Individual serum samples were stored at -20°C 
until assayed. 
Radioimmunoassays.  Id-460.  The  radioimmunoassay  used  to  quantitate  Id-460  in  mouse 
serum  was a  modification  of the solid-phase  tube  assay  of Askenase  and  Leonard  (15).  In  a 
typical experiment,  50 p,I of rabbit  anti-Id-460 antibody  (20 pg/ml)  in PBS was used  to coat 
individual wells of flexible polyvinyl microtiter plates. The plates were incubated overnight at 
4°C. After recovery of the anti-Id-460 antibody, the plates were washed with PBS and coated 
with 200 p,I of 1% BSA for 30 min at room temperature.  After three further washes with PBS, 
50 pl of dilutions of test serum or M460 standard  was added  to each well along with  10 ~1 of 
mSI-M460 (6,000 cpm/well). The plates were incubated overnight at 4°C, and then washed six 
times with distilled water. Individual wells were cut, and the counts per minute 125I bound were 
counted  in  a  gamma  counter.  The  concentration  of  Id-460  for  each  serum  sample  was 
determined by plotting the percent  125I-M460  bound versus the various dilutions of the serum 
sample. The reciprocal of the serum dilution giving 50% inhibition of binding of the I25I-M460 
was then multiplied by the concentration of M460 standard giving 50% inhibition of ~25I-M460 
to yield the concentration of Id-460 in the serum. Background counts were < 1%. Table I shows 
the specificity of this assay for various myeloma proteins. This assay does not yield parallel lines 
for the M460 as compared to serum Id-460 material  (11).  Thus, the values given for serum Id- 
TABLE  I 
Characteristics of BALB/c Myeloma Proteins and Anti-ld-460 Specificity Controls 
Tumor  ttapten specificity  Isotype  Light 
chain type 
Nanograms neces- 
sary to inhibit 
50% of le'~l-M460 
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460 levels can not be taken as absolute. Nevertheless, all the lines obtained using serum Id-460 
are  parallel,  and  thus  our  distinction  of high-  and  low-producer  strains  is  clearly  valid. 
Furthermore,  the fact that immunization with DNP leads to dramatic changes in Id-460 levels, 
coupled  with  our finding  that  the induced  Id-460 is all  removed  by passage of serum  over 
DNP-lysyl-Sepharose  (data not shown), provide strong support  for our contention that Id-460 
is produced by certain  strains as a component of their anti-DNP antibody response. 
Anti-DNP.  Anti-DNP antibody concentration was also determined  by solid-phase radioim- 
munoassay. Flexible polyvinyl microtiter  plates were coated with  10/zg DNP26-BSA/well (16). 
The plates were washed with PBS, and then blocked using 1% BSA. Serum samples at various 
125  dilutions were added to each well and allowed to react with DNP and washed.  I-antl-mouse 
Fab  (10,000 cpm/well)  was  allowed  to react  with  bound  antibody overnight  at  4°C.  The 
concentration of anti-DNP antibody for each  serum  sample was determined  by plotting the 
percent  x25I-anti-mouse Fab  bound  versus the  various  dilutions  of the  serum  sample.  The 
reciprocal of the serum dilution  giving 50% binding of x2SI-anti-mouse  Fab was th0¢l multiplied 
by the concentration of anti-DNP standard at 50% binding of 125I-anti-mouse Fab.  Standard 
anti-DNP antibody was affinity purified from a pool of mouse anti-DNP by passage over DNP- 
lysyl-Sepharose. 
Results 
The Effect of VII Genes on the Expression of ld-460.  To determine the effect of genes 
in  the  Ig-H complex  on  the  expression  of Id-460,  mice  of various  inbred  and  Ig- 
congenic strains  were  immunized  with  DNPs-OVA.  They were  bled  at  intervals, 
boosted, and again bled multiple times.  The serum was tested  for content of Id-460 
and total anti-DNP antibody in radioimmunoassay. A typical result of this study is 
shown in Fig.  1 A. A summary of the results is presented in Table II. It is clear that 
there are low levels of Id-460 in all strains reacting in our radioimmunoassay; similar 
material is found also in normal mouse serum. However, if one examines the amount 
of Id-460 found in secondary anti-DNP responses, high- and low-producer strains can 
be  discriminated.  Strains  that  produce high  levels  of Id-460 include  BALB/c and 
BAB-14, whereas  strains  giving low  levels  include  C.B20 and  B10.D2.  All of these 
mice make substantial amounts of anti-DNP antibody (>1 mg/ml). The low response 
in strain C.B20 that has the genetic background of BALB/c and that bears the Ig-H 
complex  of  C57BL/6  (Ig  b)  demonstrates  linkage  of  a  gene  required  for  Id-460 
expression to the Ig-H complex. The high response in strain BAB-14, which bears CH 
genes  from C57BL/6 and VH  genes derived mainly from strain  BALB/c, strongly 
suggests that a  gene(s) required for high levels  of Id-460 expression is located in VH. 
Further  studies  using  a  variety  of strains  have  shown  that  high  levels  of Id-460 
correlate  with  possession  of VH  genes  derived  from  BALB/c  and  low  levels  of 
expression  with  VH  derived  from C57BL/6  (Table  II).  However, one exception  to 
this  rule  is  seen;  strain  C58  does  not  express  high  levels  of Id-460 even  though  it 
possesses  the VH genes derived from BALB/c. 
The Effect of Vt¢ Genes on the Expression of ld-460.  Strain C58 was originally included 
to determine the possible contribution of VK genes to the expression of Id-460. The 
failure of C58 mice to make Id-460 could have been interpreted  in several ways. To 
clearly  test  the  involvement  of V~¢  genes  in  the  expression  of Id-460,  C.C58  and 
C.AKR congenic mice--which bear V~¢ genes from strains C58 and AKR, respectively, 
on a  BALB/c genetic background--were tested. These mice were prepared using the 
Lyt-3.1 gene product as a selecting marker (12). That they express the K-chain markers 
of AKR and C58 associated with Lyt-3.1 was confirmed by determining IB peptide, 
Ef-1 a,  and  Ef-2  marker  expression  in  these  mice  (W.-T.  Hum,  D.  Gibson,  and 724  GENETIC  CONTROL  OF  EXPRESSION  OF  IDIOTYPE  Id-460 
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FIG.  1.  Mice of various strains were immunized with 100 #g DNPs-OVA on alum plus B. pertussis 
on day 0 and boosted with 10 #g DNPs-OVA on day 21. Groups of four mice were bled, and levels 
of Id-460 and of anti-DNP antibody determined. Values represent geometric mean values, except 
in B, where individual mice are shown with a  pool serum from 10 BALB/c mice. SE <1.4, and are 
omitted. All mice made > 1 mg anti-DNP antibody during the secondary response. (A) Effect of Ig- 
H genes. (B) Effect of VK genes. (C) Effect of H-2. (D) Effect of the Xid gene. 
P.  D.  Gottlieb.  Unpublished  results.).  The  mice  were  immunized  along  with 
BALB/c  mice,  and  the  Id-460  levels  determined  at  several  times.  The  results  are 
shown in Fig.  1 B.  It  is clear that mice having V•  genes derived from strain C58 do 
not express significant amounts of Id-460 in this response, whereas mice that bear VK 
genes derived from AKR do indeed make normal levels of Id-460. Thus, expression of 
Id-460 depends on genes mapping to VK as well as to VH, and expression of Id-460 
discriminates between  the VK  genes  carried  by  AKR  and  the V~  genes  carried  by 
C58. 
The  Effect  of MHC  Genes on  Id-460 Expression.  The  effect  of  MHC  genes  on  the 
expression of Id-460 in our system was examined by immunizing strains BALB/c  (H- 
2d), BALB.B  (H-2b),  and  BALB.K  (H-2k).  These strains are congenic mice differing DZIERZAK, JANEWAY, JR., ROSENSTEIN, AND GOTTLIEB 
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only for MHC-linked  genes. The results of one of two experiments are given in Fig. 
1 C. It is clear that MHC-linked genes may have a quantitative effect on the expression 
of Id-460, but do not in any absolute way control Id-460 expression. All strains make 
strong anti-DNP  responses in this system. Ir genes that have been described  for the 
immune response to OVA do not  operate with  the  high  doses of antigen  we have 
used, and would, in any case, predict higher responses in H-2  d than in H-2  k mice. 
The Effect  of Xid Genes on Id-460 Expression.  The immune defective mouse strain 
CBA/N,  which  carries  the  Xid  gene,  and  the  FI  male  progeny  of  (CBA/N  X 
BALB/e)  matings do not express the VH-linked Id associated with the phosphoryl- 
choline-binding BALB/c myeloma protein TEPC  15, whereas the F1 female progeny 
express normal  levels of this  Id  (17).  Reciprocal  F1  male offspring of CBA/N  and 
BALB/c  parental  strains  were  immunized  with  DNPs-OVA  to  determine  if the 
expression of Id-460 was controlled or affected by the Xid gene. The results are given 
in Fig.  1 D. Although it is apparent that the nondefective F~ males make more Id-460 
than do their defective FI male counterparts, the differences are at most twofold, and 
both  sets  of mice  make  very  high  levels  of Id-460.  Thus,  the  Xid  gene  does  not 
preclude Id-460 expression in this response. 726  GENETIC CONTROl,  OF  EXPRESSION OF  ll)IOTYPE  Id-460 
TABLE  II 
Expression of ld-460 During In  Vivo Anti-DNPs-OVA Responses in  Various" Mouse Strains 
Strain  tl-2  CIt  VII  IgVK 
Geometric mean 
Xid  (×/+  relative SE) 
maximum cuncen- 
tration of Id-460 
#g/ml 
BALB/cByJ  d  a  a  +*  -  421.4)  X+  1.22 
BALB.K  k  a  a  +  -  497.8  X+  1.31 
BALB.B  b  a  a  +  -  692.9  X+  1.34] 
B.C9  b  a  a  +  -  212.6  X+  1.31 
BAB. 14  d  b  a  +  -  277.2:~ 
CBA/J  k  a  a-  +  -  264.0~ 
(BALB/c X  CBA/N)FI~3  dxk  axa-  axa-  +  -  741.4  X._. 1.22 
(CBA/N ×  BALB/c)FI~  kxd  a-xa  a-xa  +  +  561.8  X_:  1.25 
CB.20  d  b  b  +  -  53.9  X+  1.',33 
BIO.D2/oSn  d  b  b  +  -  49.3  X+  1.28 
C57BL/6  b  b  b  +  -  18.5~: 
C58/J  k  a  a  -  -  59.5  x+  1.30 
* +, VK allele associated with Lyt-3  h allele; -,  Vk allele associated with Lyt-3  a. 
Id-460 levels in pooled serum samples. 
Discussion 
In these studies, we have examined the effect upon the expression of Id-460 of four 
different gene complexes that are known to control the quantity or quality of antibody 
responses.  We  have  succeeded  in  mapping at  least  two  genes  required  for  Id-460 
expression to VH and to VK. We have also shown  that  MHC-linked  genes and the 
Xid gene have little effect on Id-460 expression. 
Most Id that have been studied demonstrate linkage to VH genes. Thus, the linkage 
of Id-460 to VH conforms to expectations for an inherited Id (1).  Furthermore, after 
the discovery ofVK polymorphisms, linkage of Id to VK genes has also been shown for 
some Id (2).  However, Id-460 is the first Id to distinguish between VK genes in strains 
C58  and  AKR.  A  recent  publication  by Gibson  and  MacLean  (8)  has  defined  a 
marker (Ef2)  that  distinguishes  VK genes of C58  from those of AKR and  BALB/c. 
The Ef2  marker appears to define a  VK group.  More recently, Gibson et  al. 2 have 
shown that K-chains from BALB/c myeloma proteins that focus at this position belong 
to the VK1 group, as does the M460 K-chain. Thus, the finding that Id-460 expression 
correlates  with  Ef2  is  supported  by  amino  acid  sequence  datafl  The  finding  of 
involvement of VK genes in  Id-460 is further strengthened  by the failure of the G-1 
monoclonal  antibody  to  inhibit  our  anti-Id-460  assay.  This  rnonoclonal  antibody 
binds to DNP and has a' VH sequence identical  to that of M460  as far as has been 
determined  (45  residues),  except  at  position  31  (P.  Gearhart.  Personal communica- 
tion.), but has a h-light chain. 
The lack of effect of the Xid gene on the expression of Id-460 is of interest because 
2 Dzierzak,  E.  A.,  R.  W.  Rosenstein,  and  C.  A. Janeway, Jr.  The  expression of an  idiotype  (Id-460) 
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this  gene  greatly influences the expression of the T15  Id.  It  has  also  been said  to 
control the expression of other Id (R. Woodland. Personal communication.). It is of 
interest to us because it is our belief that the finding of high levels of Id-460 shortly 
after boosting in the secondary response reflects the activity of a unique set of helper 
T  cells required for optimal production of anti-DNP antibody early in the response 
(18,  19). In other systems, this  helper T  cell would  appear to operate by selecting 
particular sets of B cells for activation by means of an anti-idiotypic receptor (20-22). 
Because Id-460 appears to be the dominant Id in the response to DNP-OVA expressed 
early in the secondary response,  2 and  because careful analysis of the functioning of 
this  specialized  set  of helper T  cells  in  CBA/N  mice  for  the  anti-DNP  antibody 
response has not detected any abnormalities (23), the finding of normal expression of 
Id-460 would be expected. In the T15 system, failure to express the T15 idiotype in 
(CBA/N  ×  BALB/c)F1 males  is  correlated with  the absence of the  Id-recognizing 
helper T cell set for the T15 idiotype (20). Further analysis of helper T cells for the Id- 
460 response would be expected to confirm their presence in (CBA/N × BALB/c)F1 
male mice. 
These studies can not resolve the question of whether the genes we have mapped to 
VH and VI¢ are structural or regulatory genes. The linkage of VK genetic markers to 
Lyt-3 had suggested a  possible regulatory effect of this locus on x-chain expression, 
and this was of interest because Lyt-3 is expressed on suppressor T  cells but not on 
helper T cells (24). However, gene mapping data have shown that the structural genes 
for VK are indeed on chromosome 6  (25).  Furthermore, our results show that Id-460 
expression is not controlled by Lyt-3 itself, because mice carrying Lyt-3.1 derived from 
strain AKR express the Id, whereas mice that carry Lyt-3.1 derived from strain C58 
do not express the Id. The data of Gibson et al.  (26)  strongly support the structural 
nature of this genetic difference, although activity of an unidentified regulatory gene 
linked to the structural gene still can not be excluded. 
It is clear from other work that  Id-460 expression is strongly regulated,  2 and this 
can be seen in the dramatic fluctuations observed during the course of an antibody 
response to DNP-OVA (Fig. 1). Subsequent experiments will focus on the time-course 
of expression of Id-460 at the antibody-forming-cell level, with particular attention on 
the regulation of Id within particular isotypes.  2 The cellular basis of this regulation is 
now being studied. 
Summary 
The genetic control of the expression of an idiotype (Id-460)  associated with the 
2,4-dinitrophenyl (DNP)-binding BALB/c myeloma protein MOPC 460 was studied 
using congenic strains of mice. It was shown that the expression of high levels of Id- 
460  during  secondary  in  vivo anti-DNP-ovalbumin  responses  was  determined  by 
genes  governing  immunoglobulin  heavy-chain  variable  and  r-light  chain  variable 
regions (Vr). Appropriate alleles at both loci were required for the expression of Id- 
460.  Genes  in  the  major  histocompatibility  complex  and  the  X-linked  immune 
deficiency gene found in strain CBA/N did not greatly affect Id-460 expression. The 
VK gene controlling Id-460 expression can be differentiated from Lyt-3, and it is the 
first instance in which expression of an idiotype subdivides the VK genes associated 
with the Lyt-3  a allele. Although it islikely that the VK gene(s) involved are structural, 
the involvement of a regulatory gene linked to the structural gene can not be excluded. 728  GENETIC  CONTROL  OF  EXPRESSION  OF IDIOTYPE  Id-460 
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